Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
phosphopantetheinyl transferase | 8 | 0 | 0 | 8 |
euchromatic histone-lysine N-methyltransferase 2 | 26 | 0 | 0 | 26 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 4 | 0 | 0 | 4 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 6 | 3 | 0 | 9 |
Cytochrome P450 3A4 | 0 | 6 | 0 | 9 |
5-hydroxytryptamine receptor 1A | 0 | 7 | 3 | 11 |
5-hydroxytryptamine receptor 2C | 0 | 13 | 0 | 13 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
Cytochrome P450 2C9 | 0 | 7 | 0 | 7 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 21 | 2 | 26 |
5-hydroxytryptamine receptor 2A | 0 | 14 | 0 | 15 |
Gamma-aminobutyric acid receptor subunit beta-1 | 6 | 3 | 0 | 9 |
Alpha-1B adrenergic receptor | 0 | 15 | 2 | 17 |
Translocator protein | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 6 | 3 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 6 | 3 | 0 | 9 |
D | 0 | 8 | 0 | 8 |
D(3) dopamine receptor | 0 | 8 | 0 | 8 |
5-hydroxytryptamine receptor 1A | 0 | 16 | 1 | 19 |
Alpha-2B adrenergic receptor | 0 | 12 | 2 | 15 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 6 | 3 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 6 | 3 | 0 | 9 |
D(2) dopamine receptor | 0 | 3 | 0 | 3 |
Alpha-2C adrenergic receptor | 0 | 11 | 2 | 14 |
Alpha-2A adrenergic receptor | 0 | 11 | 2 | 14 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 6 | 3 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 6 | 3 | 0 | 9 |
Alpha-1D adrenergic receptor | 0 | 15 | 2 | 18 |
Sodium-dependent dopamine transporter | 0 | 16 | 0 | 16 |
Alpha-1D adrenergic receptor | 0 | 21 | 1 | 24 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 18 | 0 | 19 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 6 | 3 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 6 | 3 | 0 | 9 |
5-hydroxytryptamine receptor 1B | 0 | 13 | 0 | 14 |
5-hydroxytryptamine receptor 1D | 0 | 6 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 6 | 3 | 0 | 9 |
5-hydroxytryptamine receptor 1F | 0 | 6 | 0 | 7 |
5-hydroxytryptamine receptor 2B | 0 | 13 | 0 | 13 |
Sodium-dependent serotonin transporter | 0 | 13 | 1 | 14 |
5-hydroxytryptamine receptor 7 | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 7 | 0 | 6 | 0 | 6 |
Alpha-1A adrenergic receptor | 0 | 9 | 2 | 13 |
Alpha-1B adrenergic receptor | 0 | 9 | 2 | 13 |
5-hydroxytryptamine receptor 3A | 0 | 4 | 0 | 4 |
Alpha-1A adrenergic receptor | 0 | 19 | 2 | 21 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 13 | 0 | 13 |
5-hydroxytryptamine receptor 7 | 0 | 6 | 0 | 6 |
D(2) dopamine receptor | 0 | 15 | 0 | 15 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 6 | 3 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit beta-3 | 6 | 3 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit beta-2 | 6 | 3 | 0 | 9 |
D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
GABA theta subunit | 6 | 3 | 0 | 9 |
Sigma non-opioid intracellular receptor 1 | 0 | 19 | 0 | 19 |
Gamma-aminobutyric acid receptor subunit epsilon | 6 | 3 | 0 | 9 |
5-hydroxytryptamine receptor 3B | 0 | 4 | 0 | 4 |
Lysosomal alpha-glucosidase | 0 | 2 | 0 | 2 |
Transporter | 0 | 11 | 0 | 11 |
ATP-dependent phosphofructokinase | 18 | 0 | 0 | 18 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 1 | 2 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 2 |
Procathepsin L | 0 | 1 | 1 | 2 |
Cathepsin B | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 0 | 0 | 1 |
Cysteine protease | 0 | 1 | 0 | 1 |
Mitochondrial 2-oxodicarboxylate carrier | 0 | 1 | 0 | 1 |
TDP1 protein | 14 | 0 | 0 | 14 |
AR protein | 18 | 0 | 0 | 18 |
glucocorticoid receptor [Homo sapiens] | 12 | 0 | 0 | 12 |
estrogen nuclear receptor alpha | 20 | 0 | 0 | 20 |
peroxisome proliferator activated receptor gamma | 10 | 0 | 0 | 10 |
ATP-binding cassette sub-family C member 3 | 0 | 18 | 0 | 18 |
Multidrug resistance-associated protein 4 | 0 | 18 | 0 | 19 |
Bile salt export pump | 0 | 25 | 0 | 25 |
Cellular tumor antigen p53 | 11 | 0 | 0 | 11 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Prostacyclin receptor | 0 | 1 | 1 | 2 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 17 | 0 | 17 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
thioredoxin reductase | 16 | 0 | 0 | 16 |
USP1 protein, partial | 13 | 0 | 0 | 13 |
NFKB1 protein, partial | 6 | 0 | 0 | 6 |
GLS protein | 14 | 0 | 0 | 14 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 13 | 0 | 0 | 13 |
cytochrome P450 2D6 | 16 | 0 | 0 | 16 |
arylsulfatase A | 11 | 0 | 0 | 11 |
cytochrome P450 2D6 isoform 1 | 8 | 0 | 0 | 8 |
D(1A) dopamine receptor | 15 | 0 | 0 | 15 |
chromobox protein homolog 1 | 13 | 0 | 0 | 13 |
atrial natriuretic peptide receptor 2 precursor | 7 | 0 | 0 | 7 |
serine/threonine-protein kinase mTOR isoform 1 | 10 | 0 | 0 | 10 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 13 | 0 | 0 | 13 |
muscarinic acetylcholine receptor M1 | 9 | 0 | 0 | 9 |
Solute carrier family 22 member 1 | 0 | 6 | 0 | 6 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 4 | 0 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 4 | 0 | 16 | 0 | 16 |
Albumin | 0 | 0 | 5 | 5 |
High affinity nerve growth factor receptor | 0 | 1 | 2 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 17 | 0 | 17 |
Muscarinic acetylcholine receptor M2 | 0 | 11 | 0 | 11 |
Muscarinic acetylcholine receptor M4 | 0 | 11 | 0 | 11 |
Muscarinic acetylcholine receptor M1 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M3 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M5 | 0 | 5 | 0 | 5 |
Muscarinic acetylcholine receptor M5 | 0 | 14 | 0 | 14 |
Alpha-2A adrenergic receptor | 0 | 18 | 1 | 19 |
Muscarinic acetylcholine receptor M2 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M1 | 0 | 14 | 0 | 14 |
Angiotensin-converting enzyme | 0 | 14 | 0 | 14 |
Alpha-2B adrenergic receptor | 0 | 16 | 0 | 16 |
Alpha-2C adrenergic receptor | 0 | 15 | 0 | 15 |
Muscarinic acetylcholine receptor M3 | 0 | 11 | 0 | 11 |
D(1A) dopamine receptor | 0 | 8 | 0 | 9 |
D(1B) dopamine receptor | 0 | 3 | 0 | 4 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 5 |
Sodium-dependent noradrenaline transporter | 0 | 24 | 4 | 28 |
Histamine H2 receptor | 0 | 8 | 0 | 8 |
5-hydroxytryptamine receptor 2A | 0 | 16 | 0 | 17 |
5-hydroxytryptamine receptor 6 | 0 | 3 | 0 | 3 |
Histamine H1 receptor | 0 | 6 | 0 | 6 |
Sodium-dependent serotonin transporter | 0 | 25 | 5 | 30 |
5-hydroxytryptamine receptor 5A | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 5B | 0 | 3 | 0 | 3 |
Histamine H1 receptor | 0 | 14 | 0 | 14 |
D(3) dopamine receptor | 0 | 16 | 2 | 22 |
Sodium channel protein type 1 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 4 subunit alpha | 0 | 4 | 0 | 4 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 16 | 0 | 17 |
Histamine H2 receptor | 6 | 3 | 0 | 11 |
D(1A) dopamine receptor | 8 | 1 | 0 | 9 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 3 | 0 | 3 |
Sodium channel protein type 7 subunit alpha | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 5 | 0 | 5 |
Sodium-dependent dopamine transporter | 0 | 19 | 3 | 22 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 19 | 0 | 19 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 5 | 0 | 5 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 7 | 0 | 7 |
Sodium channel protein type 5 subunit alpha | 0 | 7 | 0 | 7 |
Sodium channel protein type 9 subunit alpha | 0 | 4 | 0 | 4 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 4 | 0 | 3 | 0 | 3 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 12 | 0 | 12 |
Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
Ataxin-2 | 14 | 0 | 0 | 14 |
Sodium channel protein type 3 subunit alpha | 0 | 4 | 0 | 4 |
Sodium channel protein type 11 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 8 subunit alpha | 0 | 3 | 0 | 3 |
Histamine H3 receptor | 0 | 3 | 0 | 3 |
Sodium channel protein type 10 subunit alpha | 0 | 3 | 0 | 3 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 8 | 0 | 0 | 8 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 4 | 0 | 0 | 4 |
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain B, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain B, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Casein kinase II subunit alpha | 0 | 1 | 0 | 1 |
Chain A, Casein kinase II subunit alpha | 0 | 1 | 0 | 1 |
Chain A, Casein Kinase Ii Subunit Alpha | 0 | 1 | 0 | 1 |
Luciferase | 4 | 0 | 0 | 4 |
interleukin 8 | 2 | 0 | 0 | 2 |
endonuclease IV | 2 | 0 | 0 | 2 |
BRCA1 | 1 | 0 | 0 | 1 |
RGS12 | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
RAR-related orphan receptor gamma | 15 | 0 | 0 | 15 |
ATAD5 protein, partial | 10 | 0 | 0 | 10 |
PPM1D protein | 3 | 0 | 0 | 3 |
GLI family zinc finger 3 | 15 | 0 | 0 | 15 |
Microtubule-associated protein tau | 8 | 0 | 0 | 8 |
Thrombopoietin | 3 | 0 | 0 | 3 |
Smad3 | 4 | 0 | 0 | 4 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 7 | 0 | 0 | 7 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
estrogen receptor 2 (ER beta) | 10 | 0 | 0 | 10 |
nuclear receptor subfamily 1, group I, member 3 | 14 | 0 | 0 | 14 |
progesterone receptor | 12 | 0 | 0 | 12 |
regulator of G-protein signaling 4 | 11 | 0 | 0 | 11 |
EWS/FLI fusion protein | 9 | 0 | 0 | 9 |
retinoic acid nuclear receptor alpha variant 1 | 17 | 0 | 0 | 17 |
retinoid X nuclear receptor alpha | 8 | 0 | 0 | 8 |
estrogen-related nuclear receptor alpha | 16 | 0 | 0 | 16 |
farnesoid X nuclear receptor | 7 | 0 | 0 | 7 |
pregnane X nuclear receptor | 12 | 0 | 0 | 12 |
G | 9 | 0 | 0 | 9 |
Neuraminidase | 0 | 2 | 0 | 2 |
67.9K protein | 2 | 0 | 0 | 2 |
glucocerebrosidase | 2 | 0 | 0 | 2 |
Parkin | 2 | 0 | 0 | 2 |
peroxisome proliferator-activated receptor delta | 7 | 0 | 0 | 7 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 9 | 0 | 0 | 9 |
pyruvate kinase | 1 | 0 | 0 | 1 |
IDH1 | 6 | 0 | 0 | 6 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 3 | 0 | 0 | 3 |
aryl hydrocarbon receptor | 9 | 0 | 0 | 9 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 8 | 0 | 0 | 8 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 9 | 0 | 0 | 9 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 11 | 0 | 0 | 11 |
Histone H2A.x | 6 | 0 | 0 | 6 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
NPC intracellular cholesterol transporter 1 precursor | 6 | 0 | 0 | 6 |
peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 11 | 0 | 0 | 11 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 4 | 0 | 0 | 4 |
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
mitogen-activated protein kinase 1 | 7 | 0 | 0 | 7 |
flap endonuclease 1 | 6 | 0 | 0 | 6 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 4 | 0 | 0 | 4 |
nuclear receptor ROR-gamma isoform 1 | 7 | 0 | 0 | 7 |
geminin | 13 | 0 | 0 | 13 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 6 | 0 | 0 | 6 |
M-phase phosphoprotein 8 | 7 | 0 | 0 | 7 |
lamin isoform A-delta10 | 13 | 0 | 0 | 13 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 0 | 2 |
Polyphenol oxidase 2 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B10 | 0 | 2 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 5 | 0 | 0 | 5 |
G2/mitotic-specific cyclin-B2 | 0 | 1 | 0 | 1 |
Poly [ADP-ribose] polymerase tankyrase-1 | 0 | 1 | 0 | 1 |
Lysozyme C-1 | 0 | 1 | 0 | 1 |
Cationic trypsin | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 4 | 0 | 8 |
Carbonic anhydrase 2 | 0 | 4 | 0 | 8 |
Interferon beta | 13 | 0 | 0 | 13 |
HLA class I histocompatibility antigen, B alpha chain | 9 | 0 | 0 | 9 |
Transthyretin | 0 | 0 | 1 | 1 |
Estrogen receptor | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 3 | 0 | 3 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Myeloperoxidase | 0 | 5 | 0 | 5 |
Cytochrome P450 1A2 | 0 | 4 | 0 | 5 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 3 |
ATP-dependent translocase ABCB1 | 0 | 5 | 1 | 7 |
Neutrophil elastase | 0 | 2 | 0 | 2 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
Ornithine decarboxylase | 1 | 0 | 0 | 1 |
Poly [ADP-ribose] polymerase 1 | 0 | 1 | 0 | 1 |
Replicase polyprotein 1a | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
Replicase polyprotein 1ab | 0 | 3 | 1 | 4 |
Androgen receptor | 0 | 1 | 0 | 2 |
Sialidase | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase pim-1 | 0 | 1 | 0 | 2 |
Aromatase | 0 | 2 | 0 | 2 |
Cystic fibrosis transmembrane conductance regulator | 0 | 1 | 2 | 3 |
17-beta-hydroxysteroid dehydrogenase type 1 | 0 | 1 | 0 | 1 |
Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B | 0 | 1 | 0 | 1 |
Mucin-1 | 0 | 1 | 0 | 1 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 2 |
Glutamate receptor 2 | 5 | 0 | 0 | 5 |
Casein kinase II subunit alpha' | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
Acetylcholinesterase | 0 | 5 | 0 | 5 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 3 |
Amine oxidase [flavin-containing] B | 0 | 4 | 0 | 4 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 2 | 0 | 2 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 3 | 2 | 6 |
Receptor-type tyrosine-protein kinase FLT3 | 0 | 1 | 0 | 1 |
Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 2 |
Kappa-type opioid receptor | 0 | 3 | 0 | 4 |
Homeobox protein Nkx-2.5 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase SYK | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 2 | 0 | 2 |
Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
Glycogen synthase kinase-3 alpha | 0 | 1 | 0 | 1 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 0 | 1 | 1 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Death-associated protein kinase 1 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
Beta-secretase 1 | 0 | 1 | 0 | 2 |
Casein kinase II subunit beta | 0 | 1 | 0 | 1 |
Casein kinase II subunit alpha | 0 | 2 | 0 | 2 |
Urease subunit beta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 2 | 0 | 2 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
MO15-related protein kinase Pfmrk | 0 | 1 | 0 | 1 |
Inositol monophosphatase 1 | 3 | 0 | 0 | 3 |
Cyclin-dependent kinase 6 | 0 | 1 | 0 | 1 |
Cyclin-dependent-like kinase 5 | 0 | 1 | 0 | 1 |
Cyclin homolog | 0 | 1 | 0 | 1 |
Transcription factor GATA-4 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 5 activator 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 0 | 2 |
Casein kinase II subunit alpha 3 | 0 | 1 | 0 | 1 |
Inositol polyphosphate multikinase | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B3 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 9 | 0 | 0 | 9 |
Estrogen receptor beta | 0 | 1 | 0 | 1 |
Enoyl-acyl-carrier protein reductase | 0 | 1 | 0 | 1 |
Aurora kinase B | 0 | 1 | 0 | 1 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 0 | 2 |
Myocilin | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Prenyltransferase homolog | 0 | 0 | 0 | 1 |
Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
MAP kinase-interacting serine/threonine-protein kinase 2 | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
NADPH oxidase 4 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 3 | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 1 | 1 |
Inositol hexakisphosphate kinase 2 | 0 | 1 | 0 | 1 |
Short transient receptor potential channel 5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 0 | 2 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 0 | 3 |
Sialidase-2 | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 9 | 0 | 0 | 9 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 2 | 0 | 0 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
alpha-galactosidase | 2 | 0 | 0 | 2 |
lethal factor (plasmid) | 5 | 0 | 0 | 5 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 3 |
Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 4 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
glp-1 receptor, partial | 5 | 0 | 0 | 5 |
thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
Chain A, Oxygen-insensitive Nad(p)h Nitroreductase | 0 | 1 | 0 | 1 |
Chain B, Oxygen-insensitive Nad(p)h Nitroreductase | 0 | 1 | 0 | 1 |
acetylcholinesterase | 7 | 0 | 0 | 7 |
D-amino-acid oxidase | 0 | 0 | 1 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
D-amino-acid oxidase | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 5 | 0 | 0 | 1 | 1 |
Alpha-glucosidase MAL12 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 1 | 2 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
D-aspartate oxidase | 0 | 1 | 0 | 1 |
Serine racemase | 0 | 1 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
Acetylcholine receptor subunit alpha | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit gamma | 0 | 1 | 0 | 1 |
Integrin alpha-5 | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit beta | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 3 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 0 | 0 | 2 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 6 | 0 | 7 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 2 |
Acetylcholine receptor subunit delta | 0 | 1 | 0 | 1 |
Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Chitinase | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 3 | 0 | 0 | 3 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 3 | 1 | 4 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 2 | 0 | 2 |
Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 3 | 0 | 4 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 3 | 0 | 3 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 2 | 1 | 4 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Adenosine receptor A2b | 0 | 2 | 0 | 3 |
Adenosine receptor A1 | 0 | 1 | 1 | 4 |
Adenosine receptor A2a | 0 | 2 | 0 | 4 |
Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
Chitotriosidase-1 | 0 | 1 | 0 | 1 |
Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 2 | 2 | 4 |
Endochitinase B1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 0 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Guanine deaminase | 0 | 1 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 4 | 0 | 4 |
Tryptophan 5-hydroxylase 1 | 0 | 3 | 0 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Aromatase | 0 | 1 | 0 | 1 |
Spike glycoprotein | 12 | 0 | 1 | 13 |
Sigma intracellular receptor 2 | 0 | 6 | 0 | 6 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Sigma non-opioid intracellular receptor 1 | 0 | 7 | 0 | 7 |
Fumarate hydratase | 8 | 0 | 0 | 8 |
caspase 7, apoptosis-related cysteine protease | 7 | 0 | 0 | 7 |
polyprotein | 8 | 0 | 0 | 8 |
caspase-3 | 7 | 0 | 0 | 7 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 11 | 0 | 0 | 11 |
peripheral myelin protein 22 | 8 | 0 | 0 | 8 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Cytochrome P450 2D6 | 0 | 13 | 0 | 13 |
Trypanothione reductase | 0 | 2 | 0 | 2 |
Trypanothione reductase | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-6 | 0 | 0 | 2 | 2 |
Envelope glycoprotein | 0 | 0 | 4 | 4 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
SMAD family member 2 | 1 | 0 | 0 | 1 |
SMAD family member 3 | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 3 | 0 | 0 | 3 |
snurportin-1 | 3 | 0 | 0 | 3 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
plasminogen precursor | 3 | 0 | 0 | 3 |
urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
Vasopressin V2 receptor | 0 | 2 | 1 | 3 |
Oxytocin receptor | 0 | 4 | 2 | 6 |
Vasopressin V1a receptor | 0 | 3 | 1 | 4 |
Vasopressin V1b receptor | 0 | 2 | 1 | 3 |
Caspase-7 | 2 | 0 | 0 | 2 |
caspase-3 | 2 | 0 | 0 | 2 |
huntingtin isoform 2 | 2 | 0 | 0 | 2 |
ras-related protein Rab-9A | 5 | 0 | 0 | 5 |
Sodium channel protein type 1 subunit alpha | 0 | 3 | 0 | 3 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily C member 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 5 | 0 | 5 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 2 | 0 | 2 |
Transporter | 0 | 3 | 0 | 3 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Chain A, Glutamine Binding Protein | 0 | 0 | 1 | 1 |
Bloom syndrome protein isoform 1 | 5 | 0 | 0 | 5 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 3 | 0 | 0 | 3 |
Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
Amino acid transporter | 0 | 1 | 0 | 1 |
nonstructural protein 1 | 2 | 0 | 0 | 2 |
Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
Cocaine esterase | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
Major prion protein | 0 | 0 | 2 | 2 |
Vitamin D-binding protein | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
D(4) dopamine receptor | 0 | 7 | 1 | 10 |
Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
D(1B) dopamine receptor | 0 | 7 | 0 | 7 |
Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 7 | 0 | 7 |
C-8 sterol isomerase | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 3 |
Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 3 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Zinc finger protein 664 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 3 |
Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Protease | 0 | 2 | 0 | 2 |
Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 3 |
D | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 3 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 2 | 0 | 2 |
Snq2p | 0 | 0 | 0 | 2 |
activating transcription factor 6 | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 2 | 0 | 4 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
ClpP | 2 | 0 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
Metabotropic glutamate receptor 1 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 0 | 0 | 1 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 1 | 0 | 2 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
voltage-dependent T-type calcium channel subunit alpha-1H isoform a | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Vasopressin V1a receptor | 0 | 1 | 0 | 1 |
Vasopressin V1b receptor | 0 | 1 | 0 | 1 |
Oxytocin receptor | 0 | 1 | 0 | 1 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
Quinolone resistance protein NorA | 0 | 1 | 0 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 1 | 1 | 2 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Rhodopsin kinase GRK1 | 0 | 1 | 0 | 1 |
G protein-coupled receptor kinase 5 | 0 | 1 | 0 | 1 |
G protein-coupled receptor kinase 5 | 0 | 1 | 0 | 1 |
P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
Rhodopsin kinase GRK1 | 0 | 1 | 0 | 1 |
P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 0 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 2 |
Voltage-dependent calcium channel subunit alpha-2/delta-2 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 1 | 0 | 3 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 3 | 1 | 4 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 3 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 3 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 3 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 3 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 4 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 2 |
Carbonic anhydrase 14 | 0 | 0 | 0 | 2 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 3 |
Alpha-1A adrenergic receptor | 0 | 2 | 1 | 3 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily D member 3 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 1 | 2 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 1 | 1 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
GALC protein | 1 | 0 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Cathepsin D | 0 | 1 | 0 | 1 |
Aldehyde oxidase | 0 | 0 | 0 | 2 |
Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0 | 1 | 0 | 1 |
Chain A, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain K, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain B, tryptophanyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain C, Tryptophanyl-tRNA synthetase II | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Tryptophan 2,3-dioxygenase | 0 | 1 | 0 | 2 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
SLC16A10 protein | 0 | 0 | 0 | 1 |
Tryprostatin B synthase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 1 | 0 | 1 |
DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 1 | 0 | 1 |
M-phase inducer phosphatase 1 | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |